Sponsored webinar that discussed the updated Continuous Glucose Monitoring technology Standards of Care and learn about the current evidence that influenced recent changes.
On Feb. 14, AMCP joined a pharmacy stakeholder letter supporting Dr. Robert Califf's nomination for FDA Commissioner, a post he previously held in 2016.
On Feb. 9, AMCP submitted comments to CMS supporting the agency's proposal to cover anti-amyloid monoclonal antibodies through the Coverage with Evidence Development pathway.
AMCP recently caught up with Todd Hood, senior director of national accounts at Spero Therapeutics, Inc., to learn about the company and gain insights on becoming an AMCP Corporate Member.